Doctor Madhu Chintala
Janssen R&D, Spring House (United States of America)
Differential impact of milvexian, an investigational oral FXIa inhibitor vs apixaban and dabigatran on thrombin generation in human donor plasma in vitro
Event: ESC Congress 2022
Topic: Thrombosis, Bleeding
Session: Clinical and basic science insights in vascular disease
JNJ-9375, a novel exosite 1 thrombin inhibitor does not increase bleeding in a spontaneous gastrointestinal (GI) bleeding model in mice with a mutation of the Adenomatous polyposis coli (Apc) gene
Event: ESC Congress 2018
Topic: Thrombosis, Bleeding
Session: Platelets, haemostasis and coagulation
ESC 365 is supported by
